-----

Welcome to the July 2010 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, a new plan by the US government to improve intellectual property protection and secure the pharmaceutical supply chain. Plus, the developments on the bio/pharmaceutical industry efforts in corporate social responsibility and sustainability.

Outsourcing
EU Debt Crisis Adds Uncertainty
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology.
The sovereign debt crisis in the EU could greatly change the landscape for contract services.
>> Read More

Global Feature
CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and other public and private concerns. This month, we feature articles on patient capital or venture capital used to finance social enterprises, a green-assessment tool for formulated products, and a roundup of CSR and sustainability news.

more on financing social enterprises, the green-assessment tool, and a CSR roundup.

-----

Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates, and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
>> Read More

-----

INDUSTRY EVENTS

July 2010
July 10–14
Annual Meeting and Exposition of the Controlled Release Society
Portland, OR